Lineage, Inc. filed a current report on Form 8-K on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, along with supplemental earnings materials made available on its website.
Q32 Bio Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission, disclosing its financial condition, risk factors, and operational status as a clinical-stage biopharmaceutical company.
Entrada Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the fiscal quarter ended June 30, 2026.
Kymera Therapeutics, Inc. filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, disclosing its financial position and operational status as a clinical-stage biopharmaceutical company.
Shake Shack Inc. filed its Form 10-Q with the SEC on August 5, 2026, covering the quarterly period ended July 1, 2026, and reporting Shack sales of $403,437 thousand for the thirteen weeks ended on that date.
Latham Group, Inc. filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the fiscal quarter and two fiscal quarters ended June 27, 2026.
Rapport Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting on its financial condition and operations as a clinical-stage biotechnology company.
Dine Brands Global, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the fiscal quarter ended June 28, 2026.
Lakeland Financial Corporation, a Indiana-based bank holding company trading on the Nasdaq Global Select Market as LKFN, filed its Form 10-Q for the quarterly period ended June 30, 2026, on August 5, 2026, disclosing net income, balance sheet changes, and income statement details for …
NCR Voyix Corporation (NYSE: VYX) filed its quarterly report on Form 10-Q for the period ended June 30, 2026, disclosing revenue, earnings, and balance sheet data for the three and six months ended June 30, 2026.